Loading…
Beyond Air, Inc. is projected to decline to $0.3921 by 2027, a -9% move from its current price of $0.43. XAIR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.406 | $0.4296 | $0.4546 | -0.09% |
| May 30 | $0.3963 | $0.4293 | $0.465 | -0.17% |
| May 31 | $0.3889 | $0.4289 | $0.473 | -0.26% |
| Jun 1 | $0.3827 | $0.4285 | $0.4798 | -0.35% |
| Jun 2 | $0.3773 | $0.4281 | $0.4858 | -0.43% |
| Jun 3 | $0.3725 | $0.4278 | $0.4913 | -0.52% |
| Jun 4 | $0.368 | $0.4274 | $0.4963 | -0.61% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.368 | $0.4274 | $0.4963 | -0.61% |
| Week 2 | $0.3438 | $0.4248 | $0.5248 | -1.21% |
| Week 3 | $0.3259 | $0.4222 | $0.547 | -1.81% |
| Week 4 | $0.3112 | $0.4197 | $0.5659 | -2.41% |
| Week 5 | $0.2986 | $0.4171 | $0.5827 | -3.00% |
| Week 6 | $0.2874 | $0.4146 | $0.5979 | -3.59% |
| Week 7 | $0.2774 | $0.4121 | $0.612 | -4.17% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn.
It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. In addition, the company develops ultra-high concentration (UNO) that is in Phase 1 clinical trial to treat multiple solid and cutaneous tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions and autism spectrum disorder. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions.
The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
Beyond Air, Inc. (XAIR) is a healthcare company with a current price of $0.43 and a market cap of $5.46M, ranked 5260. The stock’s near-term forecast shows a mix of neutral and bearish sentiment, with 2026 expected around $0.43 on average and 2029 around $0.3083 on average, and long-term forecasts turning bullish in 2040 and 2050.
The long-run outlook envisions higher average prices and sizable upside by 2050, though there is notable volatility across the horizon.
A major floor 32.2% below — a decisive break under it would weaken the trend.
The nearest floor, 6.7% below — buyers have tended to step in here.
The nearest ceiling, 34.9% above — a clean break opens room to run.
A major ceiling 353.5% above — clearing it would confirm fresh momentum.
Key XAIR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of XAIR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.4146 | Buy | $0.4289 | Buy |
| MA 10 | $0.4491 | Sell | $0.447 | Sell |
| MA 20 | $0.4909 | Sell | $0.483 | Sell |
| MA 50 | $0.5921 | Sell | $0.6053 | Sell |
| MA 100 | $0.8594 | Sell | $0.867 | Sell |
| MA 200 | $1.38 | Sell | $1.89 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.25 | Neutral |
| Stoch RSI (14) | 48.60 | Neutral |
| CCI (20) | -85.98 | Neutral |
| Williams %R (14) | -78.83 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -16.18 | Sell |
| Bollinger %B (20,2) | 0.23 | Neutral |
| Stochastic %K (14) | 21.17 | Neutral |
| TRIX (15) | -1.21 | Sell |
| Awesome (5,34) | -0.11 | Sell |
| Ultimate (7,14,28) | 30.61 | Neutral |
| Momentum (10) | -0.11 | Sell |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 0.41 | Buy |
| ADX (14) | 24.18 | Sell |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is Bearish. RSI14 is 40, with a SMA50 of $0.5921 and a SMA200 of $1.38. Trading supports and resistances sit at $0.401 and $0.58, respectively. The 30-day range runs from $0.2963 to $0.6241, highlighting a tight but descending path amid overall weakness.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.401 | $0.43 | $0.5158 | 0% | Neutral | |
| $0.2821 | $0.3921 | $0.5895 | -9% | Neutral | |
| $0.2006 | $0.2958 | $0.4728 | -31% | Bearish | |
| $0.1986 | $0.3083 | $0.5167 | -28% | Bearish | |
| $0.2991 | $0.4865 | $0.8482 | +13% | Neutral | |
| $0.2812 | $0.4779 | $0.8619 | +11% | Neutral | |
| $0.2662 | $0.4718 | $0.877 | +10% | Neutral | |
| $0.2583 | $0.4767 | $0.9105 | +11% | Neutral | |
| $0.2035 | $0.3907 | $0.7649 | -9% | Neutral | |
| $0.2149 | $0.4287 | $0.8585 | 0% | Neutral | |
| $0.2442 | $0.5426 | $1.19 | +26% | Bullish | |
| $0.5512 | $1.22 | $2.82 | +185% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.401 | $0.43 | $0.5121 | +0.00% |
| June 2026 | $0.3603 | $0.4321 | $0.5369 | +0.48% |
| July 2026 | $0.3257 | $0.3972 | $0.5062 | -8.07% |
| August 2026 | $0.3029 | $0.3743 | $0.4864 | -5.75% |
| September 2026 | $0.3114 | $0.3892 | $0.5135 | +3.95% |
| October 2026 | $0.3085 | $0.3896 | $0.5213 | +0.11% |
| November 2026 | $0.2894 | $0.3687 | $0.4994 | -5.37% |
| December 2026 | $0.2929 | $0.3765 | $0.5158 | +2.12% |
Click any year to see its month-by-month XAIR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, XAIR could reach as high as $0.5158, with a base case around $0.43 and support toward $0.401 — roughly 0% from $0.43. A consolidation phase looks the most probable path here.
Expect XAIR to range from $0.2821 to $0.5895 through 2027. The $0.3921 average target implies a -9% move from current prices. That is -9% versus the projected 2026 average. Price action looks broadly range-bound.
The XAIR price prediction for 2028 points to an average of $0.2958 (low $0.2006, high $0.4728) — a potential decline of -31% on today's $0.43. Expect choppier, lower action through this leg of the cycle.
In 2029, XAIR is projected to trade between $0.1986 and $0.5167, averaging $0.3083 — a potential decline of -28% from today's $0.43. That is up +4% on the projected 2028 average. A cyclical pullback looks likely — prices rarely move in a straight line.
Beyond Air, Inc.'s 2030 outlook centres on $0.4865, within a $0.2991 to $0.8482 range. That is up +58% on the projected 2029 average. That marks a +13% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, XAIR could reach as high as $0.8619, with a base case around $0.4779 and support toward $0.2812 — roughly +11% from $0.43. Price action looks broadly range-bound.
Expect XAIR to range from $0.2662 to $0.877 through 2032. The $0.4718 average target implies a +10% move from current prices. That is -1% versus the projected 2031 average. A consolidation phase looks the most probable path here.
The XAIR price prediction for 2033 points to an average of $0.4767 (low $0.2583, high $0.9105) — a potential gain of +11% on today's $0.43. Price action looks broadly range-bound.
In 2034, XAIR is projected to trade between $0.2035 and $0.7649, averaging $0.3907 — a potential decline of -9% from today's $0.43. That is -18% versus the projected 2033 average. A consolidation phase looks the most probable path here.
Beyond Air, Inc.'s 2035 outlook centres on $0.4287, within a $0.2149 to $0.8585 range. That is up +10% on the projected 2034 average. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2040, XAIR could reach as high as $1.19, with a base case around $0.5426 and support toward $0.2442 — roughly +26% from $0.43. Buyers look set to stay in control over this stretch.
Expect XAIR to range from $0.5512 to $2.82 through 2050. The $1.22 average target implies a +185% move from current prices. That is up +126% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in XAIR today (≈ 2,325.581395 XAIR) could be worth
$2,848.43
+$1,848.43 (+185%) by 2050 · US Dollar
Based on the average projected XAIR price of $1.22 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in XAIRwould be worth at today's price.
$1,000 invested in XAIR on May 27, 2025 (≈ 263.157898 XAIR) would be worth
$113.16
-$886.84 (-88.7%) today · 0.11× · US Dollar
Based on a XAIR entry price of $3.8 vs. today's $0.43.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.402 | $1,069.65 | +7.0% |
| 1 month ago | $0.487 | $882.96 | -11.7% |
| 3 months ago | $0.974 | $441.48 | -55.9% |
| 6 months ago | $1.35 | $318.52 | -68.1% |
| 1 year ago | $3.8 | $113.16 | -88.7% |
| All time (5.0y) ago | $98.2 | $4.38 | -99.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our XAIR forecast.
Our base-case forecast reaches $0.86 around 2050.
Implied market cap at $0.86: $10.92M
2030 shows an avg price of $0.4865 with a min of $0.2991 and a max of $0.8482, yielding a 13.2% ROI and a Neutral sentiment. 2040 projects an avg of $0.5426, a min of $0.2442 and a max of $1.19, with a 26.2% ROI and a Bullish sentiment. 2050 forecasts an avg of $1.22, a min of $0.5512 and a max of $2.82, delivering a 184.8% ROI and a Bullish sentiment.
These figures are estimates and not guarantees, reflecting varied long-term potential with higher upside in the later horizons and significant near-term volatility.
Tap a question to reveal the answer.
Avg price $0.4865, min $0.2991, max $0.8482, ROI 13.2, sentiment Neutral.
Forecasts show a Neutral sentiment in 2026 with avg $0.43 and in 2027 with avg $0.3921, followed by Bearish readings in 2028 ($0.2958) and 2029 ($0.3083). The long-term outlook turns Neutral to Bullish by 2040 ($0.5426 avg) and remains Bullish in 2050 ($1.22 avg), with ROIs of 26.2% in 2040 and 184.8% in 2050.
Yes. The forecast shows 2040 max $1.19 and 2050 max $2.82, indicating potential to surpass $1 in the mid-to-late horizon.
Current price $0.43; Market cap $5.46M.
Bearish sentiment with RSI 14 of 40. SMA50 is $0.5921 and SMA200 is $1.38. Support sits at $0.401 and resistance at $0.58, with a 30-day range from $0.2963 to $0.6241.
Beyond Air, Inc. Community Discussion
0Share your Beyond Air, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.